Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Gallbladder and Bile Duct Disorders, Oral and gingival health research, and Hepatocellular Carcinoma Treatment and Prognosis.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
ABC-06 | A randomised phase III, multi-centre, open-label study of active symptom control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.